Michael A Metzger

Michael A Metzger has an estimated net worth of $19.3 Million. This is based on reported shares across multiple companies, which include Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, Regado Biosciences Inc, RESPONSE GENETICS INC, and Pyxis Oncology, Inc..

2021 was Michael A Metzger's most active year for acquiring shares with 17 total transactions. Michael A Metzger's most active month to acquire stocks was the month of January. 2022 was Michael A Metzger's most active year for disposing of shares, totalling 32 transactions. Michael A Metzger's most active month to dispose stocks was the month of June. 2023 saw Michael A Metzger paying a total of $11,743,518.42 for 495,959 shares, this is the most they've acquired in one year. In 2025 Michael A Metzger cashed out on 185,943 shares for a total of $2,975,555.68, their largest year based on trade value.